Palazestrant
Palazestrant (OP-1250) is an orally available and highly potent estrogen receptor antagonist and selective ER degrader with antitumor activity.Palazestrant inhibits 17b-estradiol (E2), inhibits MCF7 and CAMA-1 cell proliferation, and can be used in breast cancer research.
Product Specifications
CAS Number
2092925-89-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
449.6
Molecular Formula
C28H36FN3O
Notes
Research use only, not for human use.
Receptor
Estrogen/progestogen Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR217600L3V 200 µL
Rad52 (NM_011236) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
B2553-40E 100 µg
Bone Morphogenetic Protein 13 (BMP13, CDMP2, GDF16, GDF-6) discontinued
Sign In for Pricing
View Details VAng-Lsx06276-50gEcoli 50 µg (E. coli)
Recombinant Mycoplasma Capricolum rplN Protein (aa 1-122)
Sign In for Pricing
View Details